Special Issue "Lignans"
Deadline for manuscript submissions: closed (31 January 2019).
A printed edition of this Special Issue is available here.
Interests: medicinal chemistry; natural products total synthesis; asymmetric synthesis; bioactive natural products; polymeric materials; anticancer treatments; synthesis from biowaste-derived materials; isotopically labelled materials
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Design, Synthesis and Evaluation of New Antitumor Agents
Lignans are traditionally defined as a class of secondary metabolites that are derived from the dimersation of two or more phenylpropanoid units. Despite their common biosynthetic origins, they boast a vast structural diversity. It is also well-established that this class of compounds exhibit a range of potent biological activities. Owing to these factors, lignans have proven to be a challenging and desirable synthetic target and has instigated the development of a number of different synthetic methods, advancing our collective knowledge towards the synthesis of complex and unique structures.
This Special Issue is focused on current research concerning this notable class of compounds, ranging in scope from recent isolation and structural elucidation of new and novel compounds, biosynthetic studies to explore their origins, total syntheses and strategies towards lignan synthesis, assessment of their biological activities and potential for further therapeutic development.
Assoc. Prof. David Barker
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- total synthesis
- bioactive compounds
- natural products
- phenyl propanoids